List of bibliographic references
Number of relevant bibliographic references: 6.
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 6 | Coronavirus Infections (epidemiology) |
| 6 | Humans (MeSH) |
| 6 | Pandemics (MeSH) |
| 6 | Pneumonia, Viral (epidemiology) |
| 5 | Betacoronavirus (MeSH) |
| 5 | France (epidemiology) |
| 5 | Mental Disorders (epidemiology) |
| 4 | Antiviral Agents (therapeutic use) |
| 3 | Comorbidity (MeSH) |
| 3 | Coronavirus Infections (drug therapy) |
| 3 | Coronavirus Infections (psychology) |
| 3 | Pneumonia, Viral (drug therapy) |
| 3 | Pneumonia, Viral (psychology) |
| 2 | Age Factors (MeSH) |
| 2 | Aged, 80 and over (MeSH) |
| 2 | Antiviral Agents (pharmacokinetics) |
| 2 | Chlorpromazine (therapeutic use) |
| 2 | Drug Interactions (MeSH) |
| 2 | Drug Repositioning (MeSH) |
| 2 | Endocytosis (drug effects) |
| 2 | Hospitals, Psychiatric (organization & administration) |
| 2 | Mental Disorders (drug therapy) |
| 2 | Mental Disorders (therapy) |
| 2 | Mental Health Services (supply & distribution) |
| 2 | Pilot Projects (MeSH) |
| 2 | Single-Blind Method (MeSH) |
| 2 | Stress Disorders, Post-Traumatic (etiology) |
| 2 | Stress Disorders, Post-Traumatic (therapy) |
| 2 | Suicide (prevention & control) |
| 1 | Aftercare (MeSH) |
| 1 | Aged (MeSH) |
| 1 | Antiviral Agents (adverse effects) |
| 1 | Antiviral Agents (pharmacology) |
| 1 | Anxiety (complications) |
| 1 | Anxiety (drug therapy) |
| 1 | Anxiety (epidemiology) |
| 1 | Anxiety (pathology) |
| 1 | Attitude (MeSH) |
| 1 | Betacoronavirus (pathogenicity) |
| 1 | Biomarkers (MeSH) |
| 1 | Biotransformation (MeSH) |
| 1 | Blood-Brain Barrier (MeSH) |
| 1 | Blood-Brain Barrier (drug effects) |
| 1 | Cardiovascular Diseases (chemically induced) |
| 1 | Child (MeSH) |
| 1 | Chlorpromazine (pharmacokinetics) |
| 1 | Chlorpromazine (pharmacology) |
| 1 | Clathrin-Coated Vesicles (drug effects) |
| 1 | Clinical Trials, Phase III as Topic (methods) |
| 1 | Cognition Disorders (epidemiology) |
| 1 | Cognition Disorders (therapy) |
| 1 | Continuity of Patient Care (MeSH) |
| 1 | Continuity of Patient Care (organization & administration) |
| 1 | Coronavirus Infections (complications) |
| 1 | Coronavirus Infections (immunology) |
| 1 | Coronavirus Infections (pathology) |
| 1 | Cytochrome P-450 CYP1A2 (metabolism) |
| 1 | Cytokines (blood) |
| 1 | Disease Progression (MeSH) |
| 1 | Dose-Response Relationship, Drug (MeSH) |
| 1 | Dyspnea (drug therapy) |
| 1 | Dyspnea (epidemiology) |
| 1 | Dyspnea (pathology) |
| 1 | Dyspnea (psychology) |
| 1 | Epidemics (MeSH) |
| 1 | Fever (chemically induced) |
| 1 | France (MeSH) |
| 1 | Gastrointestinal Diseases (chemically induced) |
| 1 | Hospital Units (organization & administration) |
| 1 | Hospitals, Psychiatric (standards) |
| 1 | Hospitals, Psychiatric (statistics & numerical data) |
| 1 | Infection Control (methods) |
| 1 | Length of Stay (MeSH) |
| 1 | Lung (metabolism) |
| 1 | Mental Disorders (chemically induced) |
| 1 | Mental Disorders (etiology) |
| 1 | Mental Disorders (prevention & control) |
| 1 | Mental Health (MeSH) |
| 1 | Mental Health Services (organization & administration) |
| 1 | Mortality (MeSH) |
| 1 | Multicenter Studies as Topic (methods) |
| 1 | Patient Care Team (MeSH) |
| 1 | Patient Compliance (MeSH) |
| 1 | Patient Outcome Assessment (MeSH) |
| 1 | Patient Selection (MeSH) |
| 1 | Pharmaceutical Preparations (supply & distribution) |
| 1 | Pneumonia, Viral (complications) |
| 1 | Pneumonia, Viral (immunology) |
| 1 | Pneumonia, Viral (pathology) |
| 1 | Prisoners (psychology) |
| 1 | Psychiatry (trends) |
| 1 | Psychotic Disorders (epidemiology) |
| 1 | Psychotic Disorders (therapy) |
| 1 | Psychotropic Drugs (administration & dosage) |
| 1 | Psychotropic Drugs (adverse effects) |
| 1 | Psychotropic Drugs (pharmacokinetics) |
| 1 | Psychotropic Drugs (therapeutic use) |
| 1 | Quarantine (psychology) |
| 1 | Quarantine (statistics & numerical data) |
| 1 | Randomized Controlled Trials as Topic (methods) |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "R. Gaillard"
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i \
-Sk "R. Gaillard" \
| HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= France
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= R. Gaillard
}}
| This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021 |  |
